Differentiation of Primary Central Nervous System Lymphomas from High-Grade Gliomas by rCBV and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging

PurposePrimary central nervous system lymphoma (PCNSL) and high-grade glioma (HGG) may have similar enhancement patterns on magnetic resonance imaging (MRI), making the differential diagnosis difficult or even impractical. Relative cerebral blood volume (rCBV) and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced (DSC) perfusion MR imaging may help distinguish PCNSL from HGG. The purpose of this study was to evaluate the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of these two imaging parameters used alone or in combination for differentiating PCNSL from HGG.MethodsA total of 12 patients with PCNSL and 26 patients with HGG were examined using a 3T scanner. rCBV and percentage of signal intensity recovery were obtained and receiver operating characteristic (ROC) analysis was performed to determine optimum thresholds for tumor differentiation. Sensitivity, specificity, PPV, NPV, and accuracy for identifying the tumor types were also calculated.ResultsThe optimum threshold of 2.56 for rCBV provided sensitivity, specificity, PPV, NPV, and accuracy of 96.2, 90, 92.6, 94.7, and 93.5 %, respectively, for determining PCNSL. A threshold value of 0.89 for percentage of signal intensity recovery optimized differentiation of PCNSL and HGG with a sensitivity, specificity, PPV, NPV, and accuracy of 100, 88.5, 87, 100, and 93.5 %, respectively. Combining rCBV with the percentage of signal intensity recovery further improved the differentiation of PCNSL and HGG with a specificity of 98.5 % and an accuracy of 95.7 %.ConclusionsThe combination of rCBV measurement with percentage of signal intensity recovery can help in more accurate differentiation of PCNSL from HGG.

[1]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[2]  D. Mikulis,et al.  Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions. , 2011, AJR. American journal of roentgenology.

[3]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[4]  Kaoru Kurisu,et al.  Apparent diffusion coefficient of human brain tumors at MR imaging. , 2005, Radiology.

[5]  Sanjeev Chawla,et al.  Proton Magnetic Resonance Spectroscopy in Differentiating Glioblastomas From Primary Cerebral Lymphomas and Brain Metastases , 2010, Journal of computer assisted tomography.

[6]  M. Weller,et al.  MRI features of primary central nervous system lymphomas at presentation , 2001, Neurology.

[7]  Aidos Doskaliyev,et al.  Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T. , 2012, European journal of radiology.

[8]  P. Burger,et al.  Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to treatment. , 1986, Seminars in oncology.

[9]  J. Smirniotopoulos,et al.  Primary central nervous system lymphoma: radiologic-pathologic correlation. , 1997, Radiographics : a review publication of the Radiological Society of North America, Inc.

[10]  Glyn Johnson,et al.  Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. , 2002, Radiology.

[11]  M. Décorps,et al.  Methodology of brain perfusion imaging , 2001, Journal of magnetic resonance imaging : JMRI.

[12]  Toshinori Hirai,et al.  Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.

[13]  V. Tronnier,et al.  Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging , 2003, Neuroscience Letters.

[14]  Michael H Lev,et al.  Dynamic magnetic resonance perfusion imaging of brain tumors. , 2004, The oncologist.

[15]  S. Ng,et al.  Primary Cerebral Lymphoma and Glioblastoma Multiforme: Differences in Diffusion Characteristics Evaluated with Diffusion Tensor Imaging , 2008, American Journal of Neuroradiology.

[16]  Soonmee Cha,et al.  Perfusion MR imaging: basic principles and clinical applications. , 2003, Magnetic resonance imaging clinics of North America.

[17]  James M Provenzale,et al.  Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. , 2002, Radiology.

[18]  Glyn Johnson,et al.  Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. , 2004, AJNR. American journal of neuroradiology.

[19]  M. Hartmann,et al.  Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy , 2003, Neuroscience Letters.

[20]  T. Booth,et al.  Imaging of primary central nervous system lymphoma. , 2011, Clinical radiology.

[21]  Susan M. Chang,et al.  Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. , 2005, AJNR. American journal of neuroradiology.

[22]  Frederik L. Giesel,et al.  Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors , 2006, Neurology.

[23]  N. Bulakbaşı,et al.  Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. , 2005, AJNR. American journal of neuroradiology.

[24]  S. S. Kim,et al.  Magnetic resonance findings of primary central nervous system t‐cell lymphoma in immunocompetent patients , 2005, Acta radiologica.

[25]  E. Melhem,et al.  Differentiation between Glioblastomas, Solitary Brain Metastases, and Primary Cerebral Lymphomas Using Diffusion Tensor and Dynamic Susceptibility Contrast-Enhanced MR Imaging , 2011, American Journal of Neuroradiology.

[26]  Chan Hong Moon,et al.  Perfusion MR Imaging: Clinical Utility for the Differential Diagnosis of Various Brain Tumors , 2002, Korean journal of radiology.

[27]  M Takahashi,et al.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. , 1998, AJR. American journal of roentgenology.

[28]  R. Folkerth.  Histologic measures of angiogenesis in human primary brain tumors. , 2004, Cancer treatment and research.

[29]  H. Mehdorn,et al.  Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging. , 2003, European journal of radiology.

[30]  K Sartor,et al.  Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain-barrier. , 1999, Magnetic resonance imaging.

[31]  G Johnson,et al.  Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. , 1999, Radiology.

[32]  C. Calli,et al.  Minimum apparent diffusion coefficients in the evaluation of brain tumors. , 2005, European journal of radiology.

[33]  M. Berger,et al.  Differentiation of Glioblastoma Multiforme and Single Brain Metastasis by Peak Height and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging , 2007, American Journal of Neuroradiology.

[34]  R. Folkerth.  Descriptive Analysis and Quantification of Angiogenesis in Human Brain Tumors , 2000, Journal of Neuro-Oncology.

[35]  Bahattin Hakyemez,et al.  Evaluation of different cerebral mass lesions by perfusion‐weighted MR imaging , 2006, Journal of magnetic resonance imaging : JMRI.

[36]  C. Sarkar,et al.  Angiogenic patterns and their quantitation in high grade astrocytic tumors , 2006, Journal of Neuro-Oncology.

[37]  S. Kim,et al.  Analysis of perfusion weighted image of CNS lymphoma. , 2010, European journal of radiology.

[38]  S. Cha,et al.  Diffusion-Weighted MR Imaging Derived Apparent Diffusion Coefficient Is Predictive of Clinical Outcome in Primary Central Nervous System Lymphoma , 2010, American Journal of Neuroradiology.

[39]  A. Server,et al.  Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema , 2009, Acta radiologica.

[40]  B. Tang,et al.  Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging , 2009, Acta radiologica.

[41]  M. Lev.  Gliomatosis cerebri has normal relative blood volume: really?! Who cares? Should you? , 2002, AJNR. American journal of neuroradiology.

[42]  Glyn Johnson,et al.  Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. , 2002, Radiology.